Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate CBP-201 in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Conditions
Interventions
CBP-201
Placebo
Locations
68
United States
Connect Investigative Site 130
Birmingham, Alabama, United States
Connect Investigative Site 124
Bakersfield, California, United States
Connect Investigative Site 125
La Mesa, California, United States
Connect Investigative Site 134
Los Angeles, California, United States
Connect Investigative Site 128
Temecula, California, United States
Connect Investigative Site 119
Torrance, California, United States
Start Date
June 16, 2021
Primary Completion Date
April 15, 2022
Completion Date
June 10, 2022
Last Updated
October 17, 2023
NCT06914908
NCT05246267
NCT07125586
NCT06118554
NCT05708300
NCT07424144
Lead Sponsor
Connect Biopharm LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions